Cargando…

Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value

BACKGROUND: The DNA-repair gene DNA-dependent kinase catalytic subunit (DNA-PKcs) favours or inhibits carcinogenesis, depending on the cancer type. Its role in human hepatocellular carcinoma (HCC) is unknown. METHODS: DNA-dependent protein kinase catalytic subuni, H2A histone family member X (H2AFX)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evert, M, Frau, M, Tomasi, M L, Latte, G, Simile, M M, Seddaiu, M A, Zimmermann, A, Ladu, S, Staniscia, T, Brozzetti, S, Solinas, G, Dombrowski, F, Feo, F, Pascale, R M, Calvisi, D F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833205/ https://www.ncbi.nlm.nih.gov/pubmed/24136149 http://dx.doi.org/10.1038/bjc.2013.606

Ejemplares similares

Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury
por: Simile, Maria M., et al.
Publicado: (2018)

Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease
por: Simile, Maria M., et al.
Publicado: (2016)

Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis
por: Cigliano, Antonio, et al.
Publicado: (2017)

Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice
por: Cigliano, Antonio, et al.
Publicado: (2017)

Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase
por: Simile, Maria M., et al.
Publicado: (2021)

Experimental Models to Define the Genetic Predisposition to Liver Cancer
por: Pascale, Rosa M., et al.
Publicado: (2019)

MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes
por: Simile, Maria M., et al.
Publicado: (2019)

Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis
por: Klemm, Sophie, et al.
Publicado: (2023)

Genetic Predisposition to Hepatocellular Carcinoma
por: Pascale, Rosa M., et al.
Publicado: (2022)

S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent
por: Pascale, Rosa M., et al.
Publicado: (2022)

New cellular tools reveal complex epithelial–mesenchymal interactions in hepatocarcinogenesis
por: Sagmeister, S, et al.
Publicado: (2008)

Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: Implications for the treatment of human liver cancer
por: Wang, Chunmei, et al.
Publicado: (2013)

Deregulation of Epigenetic Mechanisms by the Hepatitis B Virus X Protein in Hepatocarcinogenesis
por: Andrisani, Ourania M.
Publicado: (2013)

Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network
por: Boult, J K R, et al.
Publicado: (2008)

The Warburg Effect 97 Years after Its Discovery
por: Pascale, Rosa Maria, et al.
Publicado: (2020)

SCD1 Expression Is Dispensable for Hepatocarcinogenesis Induced by AKT and Ras Oncogenes in Mice
por: Li, Lei, et al.
Publicado: (2013)

Exploration of Deregulated Long Non-Coding RNAs in Association with Hepatocarcinogenesis and Survival
por: Shen, Jing, et al.
Publicado: (2015)

Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant
por: Molinari, F, et al.
Publicado: (2009)

The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models
por: Ribback, Silvia, et al.
Publicado: (2016)

Oncogene-dependent function of BRG1 in hepatocarcinogenesis
por: Wang, Pan, et al.
Publicado: (2020)

Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer
por: Wang, M, et al.
Publicado: (2014)

Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis
por: Jia, Jiaoyuan, et al.
Publicado: (2020)

Sequential expression of putative stem cell markers in gastric carcinogenesis
por: Wang, T, et al.
Publicado: (2011)

Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma
por: Calvisi, Diego F., et al.
Publicado: (2012)

TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome
por: Journe, F, et al.
Publicado: (2011)

Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma
por: Pascale, Rosa M., et al.
Publicado: (2019)

Mycobacterium tuberculosis pili (MTP), a putative biomarker for a tuberculosis diagnostic test
por: Naidoo, Natasha, et al.
Publicado: (2014)

A putative OTU domain-containing protein 1 deubiquitinating enzyme is differentially expressed in thyroid cancer and identifies less-aggressive tumours
por: Carneiro, A P, et al.
Publicado: (2014)

Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
por: Cleton-Jansen, A-M, et al.
Publicado: (2009)

Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma
por: Aigelsreiter, A, et al.
Publicado: (2013)

Molecular genetic study in hepatocellular carcinoma: microRNA deregulation in multistep hepatocarcinogenesis
por: Ng, Irene Oi-Lin
Publicado: (2012)

RASSF1A independence and early galectin‐1 upregulation in PIK3CA‐induced hepatocarcinogenesis: new therapeutic venues
por: Scheiter, Alexander, et al.
Publicado: (2021)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

New insights on the role of epigenetic alterations in hepatocellular carcinoma
por: Frau, Maddalena, et al.
Publicado: (2014)

Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer
por: Senapati, S, et al.
Publicado: (2008)

An immunohistochemical perspective of PPARβ and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours
por: Ahmed, N, et al.
Publicado: (2008)

eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma
por: Steinmann, Sara M., et al.
Publicado: (2023)

MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways
por: Li, X-J, et al.
Publicado: (2013)

MDM2 is an important prognostic and predictive factor for platin–pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53
por: Walter, R F H, et al.
Publicado: (2015)

Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice
por: Hu, Junjie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_teu2a8dc7927q5v080l7eb3onh